FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...

One research group at the Clemson University Eukaryotic Pathogens Innovation Center has identified a compound that inhibits a key enzyme that brain-eating amoebas need to live, while a second ...

Now, doctors and researchers are working on other vaccines that would be beneficial in nasal spray form. Dr. Curiel says ...

Alzheimer’s disease is the most common form of dementia, affecting more than 6 million people in the United States alone. Despite extensive research, effective treatments remain limited, and the need ...

Amphastar Pharmaceuticals offers growth potential with diverse products, a solid balance sheet, and manageable risks. Find ...

Amphastar Pharmaceuticals has seen significant growth since its IPO, with its stock price increasing over 500%. Learn more ...

A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to ...

A team of scientists from Massachusetts Institute of Technology (MIT), Brigham and Women’s Hospital, Harvard Medical School ...

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on developing novel formulations and drug-delivery systems for traditional therapeutics and psychedelic treatments, ...

A study now reveals that the delivery device — through either intranasal sprayers or nebulizers — also influences the mucosal immunity and protection efficacy in non-human primates.